在轻度认知障碍或痴呆症患者中不同数字干预措施的有效性:系统性审查和网络元分析
Xin Lin1, Guangyi Xu1, Mengjiao Zhao1
1School of Nursing, Qingdao University, China.
International journal of nursing studies
|June 12, 2025
概括
移动游戏和虚拟现实是治疗轻度认知障碍 (MCI) 和痴呆症患者认知衰退的有效数字干预措施. 这些数字认知疗法在减缓认知障碍进展方面比传统方法更有效.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 数字健康数字健康
背景情况:
- 认知障碍是一个日益严重的全球健康问题,特别是在老年人群中.
- 数字认知培训为管理认知衰退提供了一种有希望的非药物学方法.
- 数字干预措施的有效性各不相同,需要进行比较分析.
研究的目的:
- 进行网络元分析,比较不同数字干预措施对轻度认知障碍 (MCI) 或痴呆症患者的疗效.
- 确定最有效的数字策略来改善全球认知,执行功能和记忆.
主要方法:
- 在主要数据库 (PubMed,科学网,Embase等) 进行系统的文献搜索. 在2025年1月1日之前.
- 包括随机对照试验 (RCT) 评估MCI或痴呆症的计算机认知干预.
- 网络元分析的一致性模型的应用,以合成有关认知结果的数据.
主要成果:
- 对涉及3182名参与者的57项RCT的分析揭示了重要的发现.
- 基于移动设备的电子游戏在缓解全球认知衰退 (SMD = 5.09) 和执行功能衰退 (SMD = 0.17) 中表现出最高的有效性.
- 沉浸式虚拟现实技术在减缓记忆衰退方面被证明是最有效的 (SMD = 2.71).
结论:
- 数字认知干预通常在管理认知障碍方面优于传统疗法.
- 移动视频游戏和沉浸式虚拟现实正在成为减缓认知衰退的领先数字干预措施.
- 这些发现支持将特定的数字工具整合到MCI和痴呆症的治疗策略中.
更多相关视频
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
6.9K
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.3K
相关概念视频
01:30Cognitive Development During Adulthood
68
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
68
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
108
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
108
01:30Dementia
107
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
107
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170